Newsroom

Truth in Hemp™ Newsroom

The need for safe, high-quality, truthful cannabinoid products has never been greater. Through quality, science, scale, and innovation, Folium Biosciences is unlocking the full potential of hemp and is committed to delivering highly refined Broad Spectrum Hemp Oil (0.0% THC) and Full Spectrum Hemp Oil with transparency, excellence, and expertise you won’t find anywhere else in the market. Folium Biosciences is often asked to contribute to various media outlets and answer questions about CBD and the world of hemp. As part of our commitment to always deliver the Truth in HempTM, we are pleased to share the latest resources, information, and company news needed to stay updated on our marketplace.

Have questions or want to help share the Truth in Hemp™?

Get in touch! We can’t wait to chat.

+
Media, News

Folium Biosciences Completes Construction of One of the World’s Largest Cannabinoid Extraction and Purification Facilities in Pueblo West, CO

Folium Biosciences has completed buildout and received a Certificate of Occupancy for the world’s largest cannabinoid extraction and purification facility, located in Pueblo West, Colo.

The new 110,000-square-foot Pueblo West facility will produce up to 22,000 kg of 0.0% THC broad spectrum CBD oil each month. To satisfy accelerating demand from CBD product manufacturers worldwide, the plant has dedicated production lines to meet CBD regulatory requirements in the US, EU, Japan, and South Korea, among other countries.

FDA registered and state-of-the-art, the new Folium facility is purpose-built for extraction, purification and formulation of cannabinoids and terpenes. The plant will utilize supercritical carbon dioxide (sCO2) extraction technology exclusively to produce phytocannabinoid-rich 0.0% THC broad spectrum CBD oil, adhering to a continuous process from decarboxylation to extraction that allows for a revolutionary inline terpene capture system.

+
Media, News

Folium Biosciences’ General Counsel, Craig Brand Presents Closing Remarks at FDA Hearings on CBD

The FDA is taking its first step in setting new regulations for cannabis Friday, holding a public hearing to dive into what its regulatory strategy should address. FDA Commissioner Scott Gottlieb has expressed concerns about companies making claims of the health benefits of CBD. But he also recognizes regulations are needed to provide clarity for companies that want to market cannabis products. Potential safety issues are expected to be a major topic at the hearing. (Fox Business)

+
Media, News

Chat News Today: New Cannabis Company Coming to Medicine Hat

A surprise announcement at Tuesday’s annual State of the City address, as hemp oil manufacturer Folium Biosciences is the newest large company to make the move to Medicine Hat. Near the end of his address in front of a packed room of hundreds of community leaders, Mayor Ted Clugston announced two plants will be constructed over the next year, which will bring 250 full-time positions once opened.